Agency Information Collection Activities; Proposed Collection; Comment Request, 14805-14806 [2013-05302]

Download as PDF 14805 Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices Deadline: Comments on this Information Collection Request must be received within 60 days of this notice. Dated: February 28, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–05303 Filed 3–6–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Information Collection Request Title: The Stem Cell Therapeutic Outcomes Database (OMB No. 0915–0310)— [Revision] Health Resources and Services Administration Agency Information Collection Activities; Proposed Collection; Comment Request ACTION: Reports Clearance Officer at (301) 443– 1984. HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Notice. SUMMARY: In compliance with the requirement for opportunity for public comment on proposed data collection projects (section 3506(c)(2)(A) of Title 44, United States Code, as amended by the Paperwork Reduction Act of 1995, Pub. L. 104–13), the Health Resources and Services Administration (HRSA) publishes periodic summaries of proposed projects being developed for submission to the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, email paperwork@hrsa.gov or call the HRSA Abstract: The Stem Cell Therapeutic and Research Act of 2005, Public Law (Pub. L.) 109–129, as amended by the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111–264 (the Act), provides for the collection and maintenance of human blood stem cells for the treatment of patients and research. HRSA’s Healthcare Systems Bureau has established the Stem Cell Therapeutic Outcomes Database. Operation of this database necessitates certain record keeping and reporting requirements in order to perform the functions related to hematopoietic stem cell transplantation under contract to the U.S. Department of Health and Human Services (HHS). The Act requires the Secretary to contract for the establishment and maintenance of information related to patients who have received stem cell therapeutic products and to do so using a standardized, electronic format. Data is collected from transplant centers by the Center for International Blood and Marrow Transplant Research and is used for ongoing analysis of transplant outcomes. HRSA uses the information in order to carry out its statutory responsibilities. Information is needed to monitor the clinical status of transplantation and to provide the Secretary of HHS with an annual report of transplant center-specific survival data. The increase in burden is due to an increase in the annual number of transplants and increasing survivorship after transplantation. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions, to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information, to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information, and to transmit or otherwise disclose the information. The total annual burden hours estimated for this Information Collection Request are summarized in the table below. The annual estimate of burden is as follows: 2013—ESTIMATED Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total responses Total burden hours Baseline Pre-TED (Transplant Essential Data) ................... Product Form (includes Infusion, HLA, and Infectious Disease Marker inserts) ........................................................ 100-Day Post-TED ............................................................... 6-Month Post-TED ............................................................... 12-Month Post-TED ............................................................. Annual Post-TED ................................................................. 200 38 7,600 0.9 6,840 200 200 200 200 200 29 38 31 27 104 5,800 7,600 6,200 5,400 20,800 1.5 0.85 1 1 1 8,700 6,460 6,200 5,400 20,800 Total .............................................................................. 200 ........................ 53,400 ........................ 54,400 Submit your comments to paperwork@hrsa.gov or mail the HRSA emcdonald on DSK67QTVN1PROD with NOTICES ADDRESSES: VerDate Mar<15>2010 18:42 Mar 06, 2013 Jkt 229001 Reports Clearance Officer, Room 10–29, PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. E:\FR\FM\07MRN1.SGM 07MRN1 14806 Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices Deadline: Comments on this Information Collection Request must be received within 60 days of this notice. Dated: February 28, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–05302 Filed 3–6–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority; Correction Health Resources and Services Administration (HRSA), HHS. ACTION: Notice; correction. AGENCY: SUMMARY: HRSA published a document in the Federal Register of January 7, 2013 (FR Doc. 2013–00032), regarding organizational changes that update the functional statements for the Office of Management. The administrative code for the Division of Information Technology (IT) Security and Records Management was incorrectly written as RBR at four occasions, on pages 956 and 957. In the Federal Register of January 7, 2013, in FR Doc. 2013–00032, on pages 956 and 957, at four occasions, correct the administrative code for the Division of Information Technology (IT) Security and Records Management to read RB5R. Dated: February 28, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–05304 Filed 3–6–13; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting emcdonald on DSK67QTVN1PROD with NOTICES Name of Committee: National Human Genome Research Institute Special Emphasis Panel: Clinically Relevant Variation Resource RFA. Date: March 14, 2013. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, 4th Floor Conference Room, 5635 Fishers Lane, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, NHGRI, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20814, 301–594–4280, mckenneyk@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: March 1, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05240 Filed 3–6–13; 8:45 am] BILLING CODE 4140–01–P Correction Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and VerDate Mar<15>2010 the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 18:42 Mar 06, 2013 Jkt 229001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel: Translational Research. Date: April 22, 2013. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: March 1, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05239 Filed 3–6–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Internal Agency Docket No. FEMA–4102– DR; Docket ID FEMA–2013–0001] Louisiana; Major Disaster and Related Determinations Federal Emergency Management Agency, DHS. AGENCY: ACTION: Notice. SUMMARY: This is a notice of the Presidential declaration of a major disaster for the State of Louisiana (FEMA–4102–DR), dated February 22, 2013, and related determinations. DATES: Effective Date: February 22, 2013. FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW., Washington, DC 20472, (202) 646–2833. Notice is hereby given that, in a letter dated February 22, 2013, the President issued a major disaster declaration under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ‘‘Stafford Act’’), as follows: SUPPLEMENTARY INFORMATION: I have determined that the damage in certain areas of the State of Louisiana E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 78, Number 45 (Thursday, March 7, 2013)]
[Notices]
[Pages 14805-14806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05302]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities; Proposed Collection; 
Comment Request

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement for opportunity for public 
comment on proposed data collection projects (section 3506(c)(2)(A) of 
Title 44, United States Code, as amended by the Paperwork Reduction Act 
of 1995, Pub. L. 104-13), the Health Resources and Services 
Administration (HRSA) publishes periodic summaries of proposed projects 
being developed for submission to the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act of 1995. To request more 
information on the proposed project or to obtain a copy of the data 
collection plans and draft instruments, email paperwork@hrsa.gov or 
call the HRSA Reports Clearance Officer at (301) 443-1984.
    HRSA specifically requests comments on: (1) The necessity and 
utility of the proposed information collection for the proper 
performance of the agency's functions, (2) the accuracy of the 
estimated burden, (3) ways to enhance the quality, utility, and clarity 
of the information to be collected, and (4) the use of automated 
collection techniques or other forms of information technology to 
minimize the information collection burden.

Information Collection Request Title: The Stem Cell Therapeutic 
Outcomes Database (OMB No. 0915-0310)--[Revision]

    Abstract: The Stem Cell Therapeutic and Research Act of 2005, 
Public Law (Pub. L.) 109-129, as amended by the Stem Cell Therapeutic 
and Research Reauthorization Act of 2010, Public Law 111-264 (the Act), 
provides for the collection and maintenance of human blood stem cells 
for the treatment of patients and research. HRSA's Healthcare Systems 
Bureau has established the Stem Cell Therapeutic Outcomes Database. 
Operation of this database necessitates certain record keeping and 
reporting requirements in order to perform the functions related to 
hematopoietic stem cell transplantation under contract to the U.S. 
Department of Health and Human Services (HHS). The Act requires the 
Secretary to contract for the establishment and maintenance of 
information related to patients who have received stem cell therapeutic 
products and to do so using a standardized, electronic format. Data is 
collected from transplant centers by the Center for International Blood 
and Marrow Transplant Research and is used for ongoing analysis of 
transplant outcomes. HRSA uses the information in order to carry out 
its statutory responsibilities. Information is needed to monitor the 
clinical status of transplantation and to provide the Secretary of HHS 
with an annual report of transplant center-specific survival data. The 
increase in burden is due to an increase in the annual number of 
transplants and increasing survivorship after transplantation.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions, to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information, to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information, and to transmit or otherwise 
disclose the information. The total annual burden hours estimated for 
this Information Collection Request are summarized in the table below.
    The annual estimate of burden is as follows:

                                                 2013--Estimated
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Form name                Number of     responses per       Total       per response    Total burden
                                    respondents     respondent       responses      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Baseline Pre-TED (Transplant                 200              38           7,600             0.9           6,840
 Essential Data)................
Product Form (includes Infusion,             200              29           5,800             1.5           8,700
 HLA, and Infectious Disease
 Marker inserts)................
100-Day Post-TED................             200              38           7,600            0.85           6,460
6-Month Post-TED................             200              31           6,200               1           6,200
12-Month Post-TED...............             200              27           5,400               1           5,400
Annual Post-TED.................             200             104          20,800               1          20,800
                                 -------------------------------------------------------------------------------
    Total.......................             200  ..............          53,400  ..............          54,400
----------------------------------------------------------------------------------------------------------------


ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA 
Reports Clearance Officer, Room 10-29, Parklawn Building, 5600 Fishers 
Lane, Rockville, MD 20857.

[[Page 14806]]

    Deadline: Comments on this Information Collection Request must be 
received within 60 days of this notice.

    Dated: February 28, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-05302 Filed 3-6-13; 8:45 am]
BILLING CODE 4165-15-P